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INTRODUCTION
Acne fulminans, also known as acne maligna, is
a rare and severe form of acne vulgaris that usually
affects young adults, predominantly Caucasian adoles-
cent males, aged 13-16 years. It is characterized by the
sudden onset of hemorrhagic ulcerative crusting acne
on the face, chest and upper back, associated with sys-
temic symptoms such as fever, weight loss, arthralgia
and myalgia in patients with a preceding history of
mild to moderate acne. 1-3 The authors report a case of
an adolescent male with acne fulminans presenting
with severe lesions that was successfully treated with
oral prednisone and dapsone.
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Abstract: Acne fulminans is a rare condition and the most severe form of acne. It involves the sudden
onset of febrile and multisystemic symptoms, with poor response to ordinary therapy in patients who
previously had mild to moderate acne. It is characterized by hemorrhagic ulcerative crusting lesions on
the face, chest and upper back. The authors report a case of acne fulminans that was successfully treated
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Resumo: A acne fulminans é uma condição rara e a mais severa forma de acne. Manifesta-se com um qua-
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CASE REPORT
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CASE REPORT
A 15-year-old man, who had been previously
diagnosed as having Grade I acne vulgaris, suddenly
developed severe worsening of the acne lesions on
the neck, arms, chest and upper back. Associated with
cutaneous lesions, he also reported fever, chills,
arthralgia and myalgia, whose intensity did not allow
locomotion and spontaneous movements in bed. 
At physical examination, he presented papules,
pustules and crusts on the face, neck and upper limbs,
and hemorrhagic ulcerations with purulent, thick, yel-
low adherent crust were scattered on the chest, upper
back and shoulders, as shown in figure 1. Laboratory
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introduced the term “acute febrile ulcerative conglo-
bate acne with polyarthralgia”.5 In 1975, Plewig and
Kligman  separated this affection from acne congloba-
ta and started to use the term acne fulminans, empha-
sizing the sudden onset and severity of this disease. 6
The aetiology of acne fulminans remains
unclear, but infection, genetic and immunological caus-
es have been postulated. One of the proposed theories
is that the development of acne fulminans is related to
an explosive immunologically mediated type III and/or
type IV hypersensitivity reaction to Propionibacterium
acnes antigens.7 Precipitation of this disease by the ini-
tiation of isotretinoin therapy has also been suspected
after the description of some cases. It is postulated that
istotretinoin induces fragility of the pilosebaceous duct
epithelium and allows massive contact of P. acnes anti-
gen with the immune system.2,8
High blood levels of testosterone may also play
an important role on the pathogenesis of acne fulmi-
nans, since there are exacerbation reports during
testosterone therapy. 9,10 Another theory is that acne
fulminans could have an autoimmune aetiology.1,2,11
Genetic factors are also considered important, as the
occurrence of acne fulminans in monozygotic twins
has already been reported.12
Acne fulminans is an extremely rare condition.
According to Karvonen (1993), approximately 100
patients were described. 8 Patients typically have mild
or moderate acne vulgaris before the onset of acute
symptoms. The dermatological manifestations are
highly inflammatory, painful, ulcerative lesions cov-
ered with haemorrhagical crusts, most often on the
upper chest and back. The face is usually less severely
involved than the trunk.3
In contrast with acne vulgaris, the systemic
symptoms of sudden onset are common in acne ful-
minans.3 These manifestations include fever, myalgia,
polyarthralgia, osteolytic bone lesions, malaise,
fatigue, anemia, leucocytosis, splenomegaly, and
hepatomegaly.3,13 Osteoarticular involvement is quite
characteristic, and it may involve large joints such as
iliosacral, ankles, shoulders and knee joints. As report-
ed in this case, patients may demonstrate a bent-over
posture because polyarthritis may make walking
painful.3
Acne fulminans is easily identified because of its
systemic features, although we also have to consider
two important differential diagnosis: acne conglobata
and rosacea fulminans. Acne conglobata usually is
found in similar locations, occurring on most of the
trunk and upper limbs, but rarely affecting the face.
However, it develops in older age, has a more chronic
course without an explosive onset, presents inflamma-
tory cystic lesions and multiple comedones, and is not
accompanied by any systemic symptoms.1-3,13 On the
tests revealed abnormal white blood cell counts (23.2
x 103/mm3; segments 84.0%, band forms 1.0%, lym-
phocytes 13.0%, monocytes 2.0%) and hemoglobin
(12.5 g/dl). The pelvic radiography did not reveal any
abnormality.
After 21 days using oral prednisone 1 mg/kg
daily and dapsone (diaminodiphenylsulfone) 100 mg
daily, ulcerative lesions began to noticeably decrease
and healed with scarring (Figure 2).
DISCUSSION
Acne fulminans was originally described in
1959 as acne conglobata with septicemia by Burns and
Colville, who described a 16-year-old youth with acute
fever and acne conglobata. 4 After that, other authors
also reported patients with acute fever, ulcerative acne
and polyarthralgia, as Kelly and Burns (1971), who
FIGURE 1: Acne fulminans. Hemorrhagic ulcerations with purulent
crust scattered on the back and neck
FIGURE 2: Patient after 21 days using oral prednisone 1mg/kg daily
and dapsone 100 mg daily
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the preferable treatment for acne fulminans is oral
prednisolone 0,5-1 mg/kg daily for 4-6 weeks with oral
isotretinoin being added to the regimen in the fourth
week, initially at 0.5 mg/kg daily and increasing grad-
ually. According to them, this protocol led to faster
control of systemic features as well as clearance of
acne when compared with other protocols. 
However, we have to consider that the use of
isotretinoin is forbidden in some countries (in Japan,
for example), and that some authors reported the risk
of this drug precipitating acne fulminans. 1,8 In this
context, other options such as dapsone (diamin-
odiphenylsulfone) and infliximab may be important.
The efficacy of dapsone to treat acne fulminans is well
established in some reports. The initial dose of dap-
sone is 50 mg daily, which can be increased to 100 or
150 mg daily.1-3,8,15 q
other hand, rosacea fulminans is also characterized by
a sudden onset, but it affects more often postadoles-
cent women, usually after a period of stress and with-
out a preceding history of acne. There are no systemic
symptoms, the lesions are localized to central areas of
the face, and comedones are rare.1 In table 1, we sum-
marized some characteristics of these diseases that are
important to establish the differential diagnosis.1
The treatment of acne fulminans is difficult and
there are many reports of different treatments. It is
important to realize that acne fulminans does not
respond to the conventional treatment for severe
acne, and the use of antibiotics is ineffective. Due the
severe systemic symptoms, bed rest and hospitaliza-
tion may be required.1-3,13 In addition to general sup-
portive care, systemic corticosteroids are the mainstay
of the therapy. Seukeran and Cunliffe14 concluded that
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TABLE 1: Differential diagnosis of acne fulminans, rosacea fulminans and acne conglobata
Acne fulminans Rosacea fulminans Acne conglobata
Gender Men Women Men
Age Adolescence (13-16 years) Postadolescence 20 – 25 years
Onset Sudden Sudden Slow
Location Face, neck, chest and back Face Trunk and upper limbs. Facial
lesions are rare
Clinical features Hemorrhagic ulcerations Comedones are rare Nodules, inflammatory cysts, 
polyporous comedones
Systemic symptoms Very common Often none None
Adapted source: Wakabayashi et al., 20111 and Jansen T, Plewig G, 199813
